|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.52 | 88.89 | 103.80 | 0.54 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Pharmaceuticals & Drugs
|
|
|
|
|
|
|
|
|
|
52-Week-High (Rs.)
|
1031.30
|
|
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
|
(Rs. in Million) | Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Audited / UnAudited | UnAudited | UnAudited | UnAudited | Audited | Net Sales | 23,713.00 | 21,593.00 | 29,557.00 | 25,793.00 | Total Expenditure | 16,890.00 | 15,966.00 | 18,147.00 | 18,068.00 | PBIDT (Excl OI) | 6,823.00 | 5,627.00 | 11,410.00 | 7,725.00 | Other Income | 1,236.00 | 6,212.00 | 824.00 | 2,512.00 | Operating Profit | 8,059.00 | 11,839.00 | 12,234.00 | 10,237.00 | Interest | 1,039.00 | 909.00 | 897.00 | 850.00 | Exceptional Items | 0 | 0 | 0 | -2,038.00 | PBDT | 7,020.00 | 10,930.00 | 11,337.00 | 7,349.00 | Depreciation | 1,277.00 | 1,249.00 | 1,212.00 | 1,199.00 | Profit Before Tax | 5,743.00 | 9,681.00 | 10,125.00 | 6,150.00 | Tax | 1,239.00 | 1,631.00 | 2,316.00 | 1,243.00 | Provisions and contingencies | 0 | 0 | 0 | 0 | Profit After Tax | 4,504.00 | 8,050.00 | 7,809.00 | 4,907.00 | Extraordinary Items | 0 | 0 | 0 | 0 | Prior Period Expenses | 0 | 0 | 0 | 0 | Other Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | Net Profit | 4,504.00 | 8,050.00 | 7,809.00 | 4,907.00 | Equity Capital | 1,012.00 | 1,012.00 | 1,012.00 | 1,012.00 | Face Value (IN RS) | 1 | 1 | 1 | 1 | Reserves | | | | | Calculated EPS | 4.45 | 7.95 | 7.72 | 4.85 | Calculated EPS (Annualised) | 17.80 | 31.82 | 30.87 | 19.40 | No of Public Share Holdings | 253,263,953.00 | 253,263,953.00 | 253,263,953.00 | 253,263,953.00 | % of Public Share Holdings | 25.02 | 25.02 | 25.02 | 25.02 | | | | | | PBIDTM% (Excl OI) | 28.77 | 26.06 | 38.60 | 29.95 | PBIDTM% | 33.99 | 54.83 | 41.39 | 39.69 | PBDTM% | 29.60 | 50.62 | 38.36 | 28.49 | PBTM% | 24.22 | 44.83 | 34.26 | 23.84 | PATM% | 18.99 | 37.28 | 26.42 | 19.02 | | Notes | Notes | Notes | Notes |
|
|
|
|
|
|